Clinical Trial

Prospective Registry of Histotripsy for Soft Tissue Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-10.
Trial Details
NCT Number NCT07470008
Lead Sponsor University of California, San Francisco
Conditions Soft Tissue Neoplasm, Soft Tissue Cancer, Soft Tissue Lesion
Enrollment 200 participants
Start Date 2026-01-29
Primary Completion 2030-08-08 (estimated)
Study Completion 2031-08-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-17